Intas enters into exclusive licence agreement with Syna to commercialise LB-0702 in gobal markets
Syna will develop and manufacture LB-0702 and supply the product to Intas and its worldwide affiliates
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
exclusive licence agreement
Myovant Sciences and Accord Healthcare enter into exclusive licence agreement to commercialise…
Myovant to receive an upfront payment of $50 million, is eligible to receive commercial launch, sales-based and other milestones…